Cumberland Pharmaceuticals, Inc. (CPIX) Tops Q3 EPS by 1c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.05 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c